Retrophin Inc (RTRX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: RTRX Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-04-12 2024-04-11 S Sale

Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
54 -0.1%
6.74
364 USD 		54 -0.1% 6.74 364 USD
2024-02-02 2024-02-01 PS Planned sale

ROTE WILLIAM E.

SENIOR VICE PRESIDENT, R&D

Officer
2,590 -3.1%
8.86
22,947 USD 		2,590 -3.1% 8.86 22,947 USD
2024-02-02 2024-02-01 S Sale

ROTE WILLIAM E.

SENIOR VICE PRESIDENT, R&D

Officer
2,174 -2.5%
8.53
18,548 USD 		2,174 -2.5% 8.53 18,548 USD
2024-02-02 2024-02-01 S Sale

Heerma Peter

CHIEF COMMERCIAL OFFICER

Officer
4,195 -4.0%
8.53
35,789 USD 		4,195 -4.0% 8.53 35,789 USD
2024-02-02 2024-02-01 S Sale

Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
3,818 -5.1%
8.53
32,573 USD 		3,818 -5.1% 8.53 32,573 USD
2024-02-02 2024-02-01 PS Planned sale

REED ELIZABETH E

SVP, GC & CORPORATE SECRETARY

Officer
2,590 -3.3%
8.86
22,947 USD 		2,590 -3.3% 8.86 22,947 USD
2024-02-02 2024-02-01 S Sale

REED ELIZABETH E

SVP, GC & CORPORATE SECRETARY

Officer
2,174 -2.7%
8.53
18,548 USD 		2,174 -2.7% 8.53 18,548 USD
2024-02-02 2024-02-01 S Sale

Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

Officer
2,820 -5.1%
8.53
24,058 USD 		2,820 -5.1% 8.53 24,058 USD
2024-02-02 2024-02-01 PS Planned sale

Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
10,016 -2.8%
8.86
88,742 USD 		10,016 -2.8% 8.86 88,742 USD
2024-02-02 2024-02-01 S Sale

Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
9,106 -2.5%
8.53
77,693 USD 		9,106 -2.5% 8.53 77,693 USD
2024-02-02 2024-02-01 S Sale

Inrig Jula

CHIEF MEDICAL OFFICER

Officer
2,174 -3.6%
8.53
18,547 USD 		2,174 -3.6% 8.53 18,547 USD
2024-01-25 2024-01-23 PS Planned sale

ROTE WILLIAM E.

SENIOR VICE PRESIDENT, R&D

Officer
2,062 -3.3%
8.96
18,476 USD 		2,062 -3.3% 8.96 18,476 USD
2024-01-25 2024-01-23 PS Planned sale

Dube Eric M

CHIEF EXECUTIVE OFFICER

Executive Director
7,873 -3.2%
8.96
70,542 USD 		7,873 -3.2% 8.96 70,542 USD
2024-01-25 2024-01-23 PS Planned sale

REED ELIZABETH E

SVP, GC & CORPORATE SECRETARY

Officer
2,062 -3.5%
8.96
18,476 USD 		2,062 -3.5% 8.96 18,476 USD
2024-01-25 2024-01-23 S Sale

Cline Christopher R.

CHIEF FINANCIAL OFFICER

Officer
853 -1.7%
9.07
7,735 USD 		853 -1.7% 9.07 7,735 USD
2024-01-25 2024-01-23 S Sale

Heerma Peter

CHIEF COMMERCIAL OFFICER

Officer
1,559 -1.9%
9.07
14,138 USD 		1,559 -1.9% 9.07 14,138 USD
2024-01-25 2024-01-23 S Sale

Calvin Sandra

SVP, CHIEF ACCOUNTING OFFICER

Officer
910 -2.2%
9.07
8,252 USD 		910 -2.2% 9.07 8,252 USD
2024-01-05 2024-01-04 PS Planned sale

Inrig Jula

Chief Medical Officer

Officer
440 -1.2%
9.17
4,035 USD 		440 -1.2% 9.17 4,035 USD
2024-01-05 2024-01-03 S Sale

Inrig Jula

Chief Medical Officer

Officer
2,069 -5.5%
9.48
19,613 USD 		2,069 -5.5% 9.48 19,613 USD
2023-10-04 2023-10-03 S Sale

Heerma Peter

Chief Commercial Officer

Officer
3,091 -3.7%
8.25
25,504 USD 		3,091 -3.7% 8.25 25,504 USD
2023-09-05 2023-09-05 PS Planned sale

Dube Eric M

Chief Executive Officer

Executive Director
4,455 -1.8%
14.71
65,533 USD 		4,455 -1.8% 14.71 65,533 USD
2023-09-05 2023-09-05 S Sale

Cline Christopher R.

Chief Financial Officer

Officer
457 -0.9%
14.71
6,723 USD 		457 -0.9% 14.71 6,723 USD
2023-09-05 2023-09-05 PS Planned sale

ROTE WILLIAM E.

Senior Vice President, R&D

Officer
1,815 -2.9%
14.71
26,699 USD 		1,815 -2.9% 14.71 26,699 USD
2023-09-05 2023-09-05 PS Planned sale

REED ELIZABETH E

SVP, GC & Corporate Secretary

Officer
1,815 -3.0%
14.71
26,699 USD 		1,815 -3.0% 14.71 26,699 USD
2023-05-12 2023-05-11 PS Planned sale

Calvin Sandra

SVP, Chief Accounting Officer

Officer
122 -0.3%
16.12
1,967 USD 		122 -0.3% 16.12 1,967 USD
2023-05-12 2023-05-10 PS Planned sale

ROTE WILLIAM E.

Senior Vice President, R&D

Officer
825 -1.4%
16.59
13,687 USD 		825 -1.4% 16.59 13,687 USD
2023-05-12 2023-05-10 S Sale

Cline Christopher R.

Chief Financial Officer

Officer
455 -0.9%
16.59
7,548 USD 		455 -0.9% 16.59 7,548 USD
2023-05-12 2023-05-10 PS Planned sale

REED ELIZABETH E

SVP, GC & Corporate Secretary

Officer
825 -1.4%
16.59
13,687 USD 		825 -1.4% 16.59 13,687 USD
2023-05-12 2023-05-10 S Sale

Calvin Sandra

SVP, Chief Accounting Officer

Officer
436 -1.0%
16.59
7,233 USD 		436 -1.0% 16.59 7,233 USD
2023-04-13 2023-04-11 S Sale

Cline Christopher R.

Chief Financial Officer

Officer
47 -0.1%
21.49
1,010 USD 		47 -0.1% 21.49 1,010 USD
2023-02-02 2023-02-02 PS Planned sale

Calvin Sandra

SVP, Chief Accounting Officer

Officer
360 -0.8%
22.42
8,071 USD 		360 -0.8% 22.42 8,071 USD
2023-02-02 2023-02-01 PS Planned sale

Dube Eric M

Chief Executive Officer

Executive Director
8,196 -3.3%
22.25
182,361 USD 		8,196 -3.3% 22.25 182,361 USD
2023-02-02 2023-02-01 S Sale

Heerma Peter

Chief Commercial Officer

Officer
1,779 -2.1%
21.75
38,697 USD 		1,779 -2.1% 21.75 38,697 USD
2023-02-02 2023-02-01 PS Planned sale

ROTE WILLIAM E.

Senior Vice President, R&D

Officer
2,590 -4.1%
22.25
57,628 USD 		2,590 -4.1% 22.25 57,628 USD
2023-02-02 2023-02-01 S Sale

Calvin Sandra

SVP, Chief Accounting Officer

Officer
1,671 -3.7%
21.75
36,348 USD 		1,671 -3.7% 21.75 36,348 USD
2023-02-02 2023-02-01 PS Planned sale

REED ELIZABETH E

SVP, GC & Corporate Secretary

Officer
2,590 -4.3%
22.25
57,628 USD 		2,590 -4.3% 22.25 57,628 USD
2023-02-02 2023-02-01 S Sale

Cline Christopher R.

Chief Financial Officer

Officer
1,588 -3.0%
21.75
34,542 USD 		1,588 -3.0% 21.75 34,542 USD
2023-01-26 2023-01-25 PS Planned sale

Calvin Sandra

SVP, Chief Accounting Officer

Officer
192 -0.5%
21.63
4,153 USD 		192 -0.5% 21.63 4,153 USD
2023-01-26 2023-01-24 S Sale

Cline Christopher R.

Chief Financial Officer

Officer
852 -2.5%
21.90
18,663 USD 		852 -2.5% 21.90 18,663 USD
2023-01-26 2023-01-24 PS Planned sale

Dube Eric M

Chief Executive Officer

Executive Director
6,442 -4.2%
21.50
138,503 USD 		6,442 -4.2% 21.50 138,503 USD
2023-01-26 2023-01-24 PS Planned sale

ROTE WILLIAM E.

Senior Vice President, R&D

Officer
2,062 -4.6%
21.50
44,333 USD 		2,062 -4.6% 21.50 44,333 USD
2023-01-26 2023-01-24 S Sale

Heerma Peter

Chief Commercial Officer

Officer
1,550 -2.4%
21.90
33,952 USD 		1,550 -2.4% 21.90 33,952 USD
2023-01-26 2023-01-24 S Sale

Calvin Sandra

SVP, Chief Accounting Officer

Officer
905 -2.5%
21.90
19,823 USD 		905 -2.5% 21.90 19,823 USD
2023-01-26 2023-01-24 PS Planned sale

REED ELIZABETH E

SVP, GC & Corporate Secretary

Officer
2,062 -4.9%
21.50
44,333 USD 		2,062 -4.9% 21.50 44,333 USD
2023-01-06 2023-01-05 PS Planned sale

Dube Eric M

Chief Executive Officer

Executive Director
5,625 -3.5%
20.75
116,719 USD 		5,625 -3.5% 20.75 116,719 USD
2023-01-06 2023-01-05 PS Planned sale

Inrig Jula

Chief Medical Officer

Officer
442 -2.5%
20.75
9,172 USD 		442 -2.5% 20.75 9,172 USD
2023-01-06 2023-01-04 S Sale

Inrig Jula

Chief Medical Officer

Officer
2,051 -10.3%
20.75
42,558 USD 		2,051 -10.3% 20.75 42,558 USD
2022-10-06 2022-10-04 S Sale

Heerma Peter

Chief Commercial Officer

Officer
3,042 -4.5%
25.68
78,119 USD 		3,042 -4.5% 25.68 78,119 USD
2022-09-15 2022-09-13 S Sale

Calvin Sandra

SVP, Chief Accounting Officer

Officer
349 -1.0%
28.00
9,772 USD 		349 -1.0% 28.00 9,772 USD
2022-05-12 2022-05-12 PS Planned sale

REED ELIZABETH E

SVP, GC & Corporate Secretary

Officer
1,050 -2.4%
21.51
22,584 USD 		1,050 -2.4% 21.51 22,584 USD
2022-05-12 2022-05-11 PS Planned sale

ROTE WILLIAM E.

Senior Vice President, R&D

Officer
813 -1.8%
21.52
17,493 USD 		813 -1.8% 21.52 17,493 USD
2022-05-12 2022-05-11 PS Planned sale

ROTE WILLIAM E.

Senior Vice President, R&D

Officer
750 -1.7%
21.93
16,448 USD 		750 -1.7% 21.93 16,448 USD
2022-05-12 2022-05-11 PS Planned sale

Clague Laura

Chief Financial Officer

Officer
1,375 -3.7%
21.51
29,576 USD 		1,375 -3.7% 21.51 29,576 USD
2022-05-12 2022-05-11 S Sale

Calvin Sandra

SVP, Chief Accounting Officer

Officer
445 -1.2%
21.92
9,756 USD 		445 -1.2% 21.92 9,756 USD
2022-05-12 2022-05-11 S Sale

ASELAGE STEVE

Non-Executive Director
2,575 -1.7%
21.92
56,457 USD 		2,575 -1.7% 21.92 56,457 USD
2022-05-12 2022-05-10 PS Planned sale

REED ELIZABETH E

SVP, GC & Corporate Secretary

Officer
900 -2.1%
21.51
19,359 USD 		900 -2.1% 21.51 19,359 USD
2022-05-12 2022-05-10 PS Planned sale

Clague Laura

Chief Financial Officer

Officer
825 -2.2%
21.51
17,746 USD 		825 -2.2% 21.51 17,746 USD
2022-05-12 2022-05-10 S Sale

Calvin Sandra

SVP, Chief Accounting Officer

Officer
436 -1.2%
21.51
9,378 USD 		436 -1.2% 21.51 9,378 USD
2022-02-11 2022-02-10 PS Planned sale

Dube Eric M

Chief Executive Officer

Executive Director
4,832 -2.9%
27.84
134,523 USD 		4,832 -2.9% 27.84 134,523 USD
2022-02-02 2022-01-31 PS Planned sale

Clague Laura

Chief Financial Officer

Officer
1,238 -3.2%
27.40
33,921 USD 		1,238 -3.2% 27.40 33,921 USD
2022-02-02 2022-01-31 PS Planned sale

REED ELIZABETH E

SVP, GC & Corporate Secretary

Officer
1,350 -3.0%
27.40
36,990 USD 		1,350 -3.0% 27.40 36,990 USD
2022-02-02 2022-01-31 PS Planned sale

Heerma Peter

Chief Commercial Officer

Officer
1,125 -1.6%
27.40
30,825 USD 		1,125 -1.6% 27.40 30,825 USD
2022-02-02 2022-01-31 PS Planned sale

Dube Eric M

Chief Executive Officer

Executive Director
4,813 -2.8%
27.40
131,876 USD 		4,813 -2.8% 27.40 131,876 USD
2022-02-02 2022-01-31 PS Planned sale

ROTE WILLIAM E.

Senior Vice President, R&D

Officer
1,125 -2.4%
27.40
30,825 USD 		1,125 -2.4% 27.40 30,825 USD
2022-02-02 2022-01-31 S Sale

Calvin Sandra

VP, Corp Controller and CAO

Officer
798 -2.1%
26.51
21,152 USD 		798 -2.1% 26.51 21,152 USD
2022-01-26 2022-01-24 S Sale

Calvin Sandra

VP, Corp Controller and CAO

Officer
934 -3.2%
24.58
22,955 USD 		934 -3.2% 24.58 22,955 USD
2022-01-26 2022-01-24 PS Planned sale

ROTE WILLIAM E.

Senior Vice President, R&D

Officer
1,875 -4.9%
24.98
46,838 USD 		1,875 -4.9% 24.98 46,838 USD
2022-01-26 2022-01-24 PS Planned sale

Clague Laura

Chief Financial Officer

Officer
2,063 -6.6%
24.98
51,534 USD 		2,063 -6.6% 24.98 51,534 USD
2022-01-26 2022-01-24 PS Planned sale

Heerma Peter

Chief Commercial Officer

Officer
1,875 -3.1%
24.98
46,838 USD 		1,875 -3.1% 24.98 46,838 USD
2022-01-26 2022-01-24 PS Planned sale

REED ELIZABETH E

SVP, GC & Corporate Secretary

Officer
2,250 -6.0%
24.98
56,205 USD 		2,250 -6.0% 24.98 56,205 USD
2022-01-26 2022-01-24 PS Planned sale

Dube Eric M

Chief Executive Officer

Executive Director
7,873 -5.6%
24.98
196,668 USD 		7,873 -5.6% 24.98 196,668 USD
2022-01-12 2022-01-11 PS Planned sale

Clague Laura

Chief Financial Officer

Officer
7,500 -19.3%
27.40
205,500 USD 		7,500 -19.3% 27.40 205,500 USD
2022-01-12 2022-01-11 PS Planned sale

REED ELIZABETH E

SVP, GC & Corporate Secretary

Officer
5,000 -11.8%
27.40
137,000 USD 		5,000 -11.8% 27.40 137,000 USD
2022-01-12 2022-01-11 PS Planned sale

ROTE WILLIAM E.

Senior Vice President, R&D

Officer
2,500 -6.1%
27.40
68,500 USD 		2,500 -6.1% 27.40 68,500 USD
2022-01-06 2022-01-05 PS Planned sale

Dube Eric M

Chief Executive Officer

Executive Director
2,139 -1.5%
30.48
65,197 USD 		2,139 -1.5% 30.48 65,197 USD